NASDAQ · OBSV
Healthcare · Biotechnology
$0.10
Up+$0.00 (+0.00%)
Updated Sep 11, 2026, 1:02 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
OBSV does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
The latest Smart Investors Daily articles mentioning OBSV.
OBSV research
Company profile and research snapshot.
ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company is also involved in developing Ebopiprant, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, which is in Phase II clinical trial as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist that is in Phase I clinical trial to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. ObsEva SA was founded in 2012 and is headquartered in Geneva, Switzerland.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 30, 2022 | HC Wainwright & Co. | Neutral | — |
| Jun 3, 2022 | Cantor Fitzgerald | Overweight | — |
| Apr 26, 2022 | Canaccord Genuity | Buy | — |
| Mar 28, 2022 | HC Wainwright & Co. | Buy | — |
| Mar 28, 2022 | Aegis Capital | Buy | — |
No generated briefing is available yet.
GlobeNewswire Inc. · Mar 15, 2023
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
GlobeNewswire Inc. · Mar 13, 2023
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange
PennyStocks · Mar 6, 2023
These indicators can help you to make money with penny stocks The post The Most Important Penny Stocks Trading Indicators appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
PennyStocks · Mar 5, 2023
Use these tips for making money with penny stocks in 2023 The post Penny Stocks Trading: How News Plays a Role appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning OBSV.
No results
No recent SID articles mention OBSV.
